Sign In
Buy QDEL
$13.60
+0.310 (+2.33%)
At Close: Jun 03, 2026
4 MedTech Stocks Poised to Outshine Q1 Earnings Estimates
08:30am, Thursday, 01'st May 2025
MedTech companies' quarterly results are likely to reflect base business recovery on a year-over-year basis. Let's see how HIMS, GMED, QDRL and HAE are poised ahead of their earnings release.
QuidelOrtho (QDEL) Earnings Expected to Grow: Should You Buy?
11:06am, Wednesday, 30'th Apr 2025
QuidelOrtho (QDEL) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Why QuidelOrtho (QDEL) Could Beat Earnings Estimates Again
01:15pm, Thursday, 24'th Apr 2025
QuidelOrtho (QDEL) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
QuidelOrtho to Report First Quarter 2025 Financial Results
04:30pm, Wednesday, 23'rd Apr 2025
SAN DIEGO--(BUSINESS WIRE)--QuidelOrtho Corporation (Nasdaq: QDEL) (the “Company”) or (“QuidelOrtho”), a global provider of innovative in-vitro diagnostic technologies designed for point-of-ca
QuidelOrtho (QDEL) Surges 10.1%: Is This an Indication of Further Gains?
12:35pm, Thursday, 10'th Apr 2025
QuidelOrtho (QDEL) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Reasons to Retain QuidelOrtho Stock in Your Portfolio for Now
02:35pm, Wednesday, 09'th Apr 2025
QDEL continues to witness growth on the back of its strong product portfolio.
QuidelOrtho Unveils Results Manager System to Streamline Testing
11:05am, Friday, 14'th Mar 2025
QDEL introduces the Results Manager System, a powerful tool designed to streamline diagnostic data management, enhance efficiency, and improve patient care.
QuidelOrtho® Introduces Results Manager™ System
09:00am, Monday, 10'th Mar 2025
SAN DIEGO--(BUSINESS WIRE)--QuidelOrtho Corporation (Nasdaq: QDEL) (“QuidelOrtho”) announces the availability of the QuidelOrtho® Results Manager™ System, an informatics solution designed to ad
Why QuidelOrtho Stock Bounced More Than 4% Higher Today
06:19pm, Thursday, 13'th Feb 2025
Healthcare in vitro diagnostics company QuidelOrtho (QDEL 4.28%) attracted the right kind of attention from investors after posting its latest quarterly earnings report on Thursday. A rather encourage
QuidelOrtho Stock Gains Following Q4 Earnings Beat, Margins Contract
11:57am, Thursday, 13'th Feb 2025
Despite solid performances by the Labs and Immunohematology units and China and Other regions, QDEL reports soft overall top-line results in fourth-quarter 2024.
QuidelOrtho Corporation (QDEL) Q4 2024 Earnings Call Transcript
07:50pm, Wednesday, 12'th Feb 2025
QuidelOrtho Corporation (NASDAQ:QDEL ) Q4 2024 Results Conference Call February 12, 2025 5:00 PM ET Company Participants Juliet Cunningham - Vice President, Investor Relations Brian Blaser - President
QuidelOrtho (QDEL) Q4 Earnings and Revenues Top Estimates
06:41pm, Wednesday, 12'th Feb 2025
QuidelOrtho (QDEL) came out with quarterly earnings of $0.63 per share, beating the Zacks Consensus Estimate of $0.55 per share. This compares to earnings of $1.17 per share a year ago.
QuidelOrtho Reports Fourth Quarter and Full-Year 2024 Financial Results
04:05pm, Wednesday, 12'th Feb 2025
SAN DIEGO--(BUSINESS WIRE)--QuidelOrtho Corporation (Nasdaq: QDEL) (the “Company” or “QuidelOrtho”), a global provider of innovative in-vitro diagnostic technologies designed for point-of-care
Reasons to Retain QuidelOrtho Stock in Your Portfolio for Now
11:56am, Thursday, 30'th Jan 2025
QDEL continues to witness growth on the back of its strong product portfolio.
QuidelOrtho Stock Down Despite Solid Preliminary Q4 Revenues
12:50pm, Tuesday, 14'th Jan 2025
QDEL's preliminary fourth-quarter revenues align with the company's expectations.
